Fabrizio Miranda

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Current screening methods for ovarian cancer can only detect advanced disease. Earlier detection has proved difficult because the molecular precursors involved in the natural history of the disease are unknown. To identify early driver mutations in ovarian cancer cells, we used dense whole genome sequencing of micrometastases and microscopic residual(More)
  • 1